2025年全球器官保存解決方案市場報告

預計未來幾年器官保存解決方案市場規模將強勁成長。到 2029 年，這一數字將成長至 4,525.9 億美元，年複合成長率（CAGR）為 9.4%。預測期內的成長可以歸因於對擴大標準器官的需求不斷增加、器官採購計劃的擴大、對器官質量和功能的重視以及全球為解決器官短缺問題所做的努力。預測期內的關鍵趨勢包括器官庫中保存解決方案的應用、市場對延長保存時間的關注、增強保存的添加劑的整合、對攜帶式和緊湊型器官保存設備的關注以及器官保存研究和創新的合作。

預計器官移植數量的激增可能會在未來幾年推動器官保存解決方案市場的成長。器官移植是一種從捐贈者提取器官和組織並移植到接受者的外科手術，依靠器官保存液來減輕運輸和儲存過程中的損傷，從而提高器官成功移植的可行性。例如，根據美國器官取得與移植網路（OPTN）2023年1月的資料，2022年的器官移植數量從2021年的41,354例增加了3.7%，達到42,887例。其中，腎臟移植佔比最大，為2.5萬例，在美國增加了3.4%。因此，器官移植的增加是器官保存解決方案市場的主要動力。

器官保存解決方案市場的成長受到醫療保健支出增加的推動。該術語指的是分配給特定地區、國家或組織內醫療保健部門的總財政資源。醫療保健支出正在採用器官保存解決方案，以提高器官移植手術的成功率。這些解決方案對於在運輸和儲存過程中保存器官並確保其移植的可行性至關重要。投資器官保存解決方案可以改善器官移植的結果，最終減少額外移植的需求和相關的醫療保健費用。例如，2023年11月，加拿大衛生資訊研究所預測，2023年加拿大的醫療保健總支出將達到3,440億美元，即每人8,740美元。與前一年相比，這一數字成長了 2.8%，而 2022 年的成長僅為 1.5%，凸顯了醫療保健投資的強勁復甦。因此，醫療保健支出的增加將推動未來幾年器官保存解決方案市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球器官保存解決方案PESTEL分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
• 最終用途產業分析
• 全球器官保存解決方案市場：成長率分析
• 全球器官保存解決方案市場表現：規模與成長，2019-2024
• 全球器官保存解決方案市場預測：規模與成長，2024-2029 年，2034 年
• 全球器官保存解決方案總目標市場（TAM）

第6章市場區隔

• 全球器官保存解決方案市場（按解決方案類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
• Viaspan
• Custodiol-HTK（組胺酸-色胺酸-酮戊二酸）
• Renograf
• 低溫
• Perfadex
• 改革
• HBS（高滲透壓血液替代品）溶液
• siRNA（小干擾RNA）遞送溶液
• 其他解決方案類型
• 全球器官保存解決方案市場（依器官類型、績效及預測），2019-2024 年、2024-2029 年及 2034 年
• 腎
• 肝
• 肺
• 心
• 其他器官類型
• 全球器官保存解決方案市場（按技術、績效和預測），2019-2024 年、2024-2029 年及 2034 年
• 靜態冷凍（SCS）技術
• 低溫機灌注
• 其他技術
• 全球器官保存解決方案市場，按類型細分： Viaspan，實際及預測，2019-2024 年，2024-2029 年，2034 年
• 標準Viaspan
• 改進的Viaspan配方
• 全球器官保存解決方案市場，按類型細分：Custodioiol-HTK（組氨酸-色氨酸-酮戊二酸），實際及預測，2019-2024 年、2024-2029 年、2034 年
• 監護準備
• 含添加劑的變體
• 全球器官保存解決方案市場，按類型細分：Renograf、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 腎臟保存的Renograf解決方案
• 特殊Renograf配方
• 全球器官保存解決方案市場，按類型細分：低溫療法、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 各器官的低溫治療
• 自訂低溫混合物
• 全球器官保存解決方案市場，按類型細分：Perfadex，實際及預測，2019-2024 年、2024-2029 年、2034 年
• Perfadex用於肺部保存
• 自適應 Perfadex 配方
• 全球器官保存解決方案市場，按類型細分：器官保存、實際及預測，2019-2024 年、2024-2029 年、2034 年
• Lifor 用於多重器官保存
• 適應症的具體內容
• 全球器官保存解決方案市場，按類型細分：HBS（高滲透壓血液替代品）解決方案，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 哈佛商學院器官移植
• 特別的哈佛商學院準備
• 全球器官保存解決方案市場，按類型細分：siRNA（小干擾 RNA）植入解決方案，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 基於siRNA的保存方法
• siRNA應用的創新
• 全球器官保存解決方案市場，按類型細分：其他解決方案類型，實際及預測，2019-2024 年、2024-2029 年、2034 年
• 實驗性保存解決方案
• 新的器官保存技術

第7章 區域和國家分析

• 全球器官保存解決方案市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球器官保存解決方案市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 器官保存解決方案市場：競爭格局
• 器官保存解決方案市場：公司簡介
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Accord Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • BioLife Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Lifeline Scientific Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• TransMedics Group Inc.
• XVIVO Perfusion AB
• Organ Recovery Systems Inc.
• Bridge to Life Ltd.
• Paragonix Technologies Inc.
• OrganOx Limited
• Shanghai Genext Pharmaceutical Technology
• 21st Century Medicine
• Institut Georges Lopez
• Carnamedica
• Global Transplant Solutions
• Preservation Solutions Inc.
• Essential Pharmaceuticals LLC
• Dr. Franz Kohler Chemie GmbH
• Advanced Organ Preservation Solutions（OPSL Group）

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年器官保存解決方案市場：提供新機會的國家
• 2029 年器官保存解決方案市場：細分領域帶來新機會
• 器官保存解決方案市場 2029：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

Organ preservation solutions are specially formulated solutions designed for the preservation of organs during transplantation or storage. These solutions play a crucial role in safeguarding organs from potential damage during the transplantation process and extending the period for which organs can be stored outside of the body. Organ preservation solutions are formulated with specific agents that aim to mitigate ischemia-reperfusion injury (IRI) by employing targeted mechanisms of action.

There are several main types of organ preservation solutions, including Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, HBS (Hyperosmotic Blood Substitute) Solution, siRNA (Small Interfering RNA) Transplant Solutions, and others. Viaspan, for example, is utilized for the cold storage preservation of solid organs such as the liver, pancreas, and kidneys. It plays a crucial role in maintaining organ viability during transportation and before transplantation. These solutions are employed in preserving various organs, including kidneys, liver, lungs, hearts, and others, utilizing techniques such as static cold storage (SCS) and hypothermic machine perfusion. These preservation techniques are essential for ensuring the successful transplantation of organs and improving overall patient outcomes.

The organ preservation solution research report is one of a series of new reports from The Business Research Company that provides organ preservation solution market statistics, including the organ preservation solution industry's global market size, regional shares, competitors with an organ preservation solution market share, detailed organ preservation solution market segments, market trends and opportunities, and any further data you may need to thrive in the organ preservation solution industry. This organ preservation solution market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The organ preservation solution market size has grown strongly in recent years. It will grow from $293.99 billion in 2024 to $316.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to a rise in organ transplants, growing awareness of organ donation, expansion of healthcare infrastructure, and increasing incidence of organ failure

The organ preservation solution market size is expected to see strong growth in the next few years. It will grow to $452.59 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising demand for extended criteria organs, expansion of organ procurement programs, focus on organ quality and functionality, and global initiatives to address organ shortage. Major trends in the forecast period include the application of preservation solutions in organ banking, market emphasis on extended preservation times, integration of additives for enhanced preservation, focus on portable and compact organ preservation devices, and collaborations for research and innovation in organ preservation.

The anticipated surge in organ transplantation is poised to drive the growth of the organ preservation solution market in the coming years. Organ transplantation, a surgical procedure involving the extraction and transfer of organs or tissues from a donor to a recipient, relies on organ preservation solutions to mitigate damage during transportation and storage, thereby enhancing organ viability for successful transplantation. For instance, data from the Organ Procurement and Transplantation Network (OPTN) in January 2023 revealed a 3.7 percent increase in organ transplants in 2022, totaling 42,887 procedures compared to 41,354 in 2021. Kidney transplants, constituting a significant share with 25,000 procedures, exhibited a 3.4 percent growth in the United States. Consequently, the upswing in organ transplantation is a key driver for the organ preservation solution market.

The growth of the organ preservation solution market is being propelled by rising healthcare spending. This term refers to the total financial resources allocated to the healthcare sector within a specific region, country, or organization. Healthcare spending employs organ preservation solutions to enhance the success rates of organ transplantation procedures. These solutions are essential for preserving organs during transportation and storage, ensuring their viability for transplantation. Investing in organ preservation solutions leads to improved outcomes for organ transplants, which in turn can reduce the need for additional transplantations and lower associated healthcare costs. For instance, in November 2023, the Canadian Institute for Health Information, a Canada-based organization, projected that total health spending in Canada would reach $344 billion in 2023, which amounts to $8,740 per person. This represents a 2.8% increase compared to the previous year, which saw a growth rate of only 1.5% in 2022, highlighting a significant rebound in healthcare investment. Therefore, the increase in healthcare spending is driving the growth of the organ preservation solution market in the coming years.

Product innovation is a significant trend gaining traction in the organ preservation solution market. Leading companies in this sector are concentrating on developing cutting-edge products to enhance their position and secure a competitive edge. For example, in June 2024, Paragonix Technologies, a US-based firm specializing in organ preservation technology, introduced the PancreasPak Organ Preservation System. This device is the first to receive FDA clearance specifically designed to protect and monitor donor pancreases during transportation, underscoring its crucial role in organ transplantation. The system creates a controlled environment that maintains the pancreas at an optimal thermal range of 4-8°C, which is vital for preserving the organ's viability and functionality during transport, which can last up to 21 hours. The PancreasPak is also equipped with digital monitoring capabilities that continuously track the temperature and surrounding conditions of the pancreas. This real-time data facilitates immediate action in response to any deviations from optimal conditions, thereby enhancing organ preservation.

Moreover, major companies in the organ preservation solution market are actively pursuing technological advancements, particularly in the realm of organ tracking technology, as a strategic move to enhance their competitive standing in organ transportation. Organ tracking technology involves a spectrum of tools and systems dedicated to monitoring the location and condition of organs during transit. In October 2022, Paragonix Technologies Inc. unveiled its VantagePoint organ tracking technology, providing real-time tracking capabilities for donor organs in transit. This technology aims to enhance transparency and accountability in donor organ transportation, augmenting the digital tracking capabilities offered by the Paragonix App.

In September 2024, Getinge, a Sweden-based medical technology firm, acquired Paragonix Technologies for $253 million. This acquisition enables Getinge to enter the fast-growing organ preservation and transportation market, which is witnessing substantial growth driven by rising transplant volumes and technological advancements. Paragonix Technologies is a US-based biotechnology company specializing in organ preservation solutions.

Major companies operating in the organ preservation solution market include Bristol-Myers Squibb Company, Baxter International Inc., Accord Healthcare, BioLife Solutions Inc., Lifeline Scientific, TransMedics Group Inc., XVIVO Perfusion AB, Organ Recovery Systems Inc., Bridge to Life Ltd., Paragonix Technologies Inc., OrganOx Limited, Shanghai Genext Pharmaceutical Technology, 21st Century Medicine, Institut Georges Lopez, Carnamedica, Global Transplant Solutions, Preservation Solutions Inc., Essential Pharmaceuticals LLC, Dr. Franz Kohler Chemie GmbH, Advanced Organ Preservation Solutions (OPSL Group), Vascular Perfusion Solutions Inc., Transplant Biomedicals SL

North America was the largest region in the organ preservation solution market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organ preservation solution market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the organ preservation solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The organ preservation solution market consists of sales of the histidine-tryptophan-ketoglutarate solution and hypertonic citrate adenine solution. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Organ Preservation Solution Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on organ preservation solution market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for organ preservation solution ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The organ preservation solution market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Solution Type: Viaspan; Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate); Renograf; Hypothermosol; Perfadex; Lifor; HBS (Hyperosmotic Blood Substitute) Solution; siRNA (Small Interfering RNA) Transplant Solutions; Other Solution Types
• 2) By Organ Type: Kidneys; Liver; Lung; Heart; Other Organ Types
• 3) By Technique: Static Cold Storage (SCS) Technique; Hypothermic Machine Perfusion; Other Techniques
• Subsegments:
• 1) By Viaspan: Standard Viaspan; Modified Viaspan Formulations
• 2) By Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate): Custodiol Formulations: Variants With Additives
• 3) By Renograf: Renograf Solutions For Kidney Preservation; Specialty Renograf Formulations
• 4) By Hypothermosol: Hypothermosol For Various Organs; Custom Hypothermosol Mixes
• 5) By Perfadex: Perfadex For Lung Preservation; Adapted Perfadex Formulations
• 6) By Lifor: Lifor For Multi-Organ Preservation; Specific Lifor Adaptations
• 7) By HBS (Hyperosmotic Blood Substitute) Solution: HBS For Organ Transport; Specialty HBS Formulations
• 8) By siRNA (Small Interfering RNA) Transplant Solutions: siRNA-Based Preservation Methods; Innovations In siRNA Applications
• 9) By Other Solution Types: Experimental Preservation Solutions; Emerging Organ Preservation Technologies
• Companies Mentioned: Bristol-Myers Squibb Company; Baxter International Inc.; Accord Healthcare; BioLife Solutions Inc.; Lifeline Scientific
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Organ Preservation Solution Market Characteristics

3. Organ Preservation Solution Market Trends And Strategies

4. Organ Preservation Solution Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Organ Preservation Solution Growth Analysis And Strategic Analysis Framework

• 5.1. Global Organ Preservation Solution PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Organ Preservation Solution Market Growth Rate Analysis
• 5.4. Global Organ Preservation Solution Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Organ Preservation Solution Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Organ Preservation Solution Total Addressable Market (TAM)

6. Organ Preservation Solution Market Segmentation

• 6.1. Global Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viaspan
• Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate)
• Renograf
• Hypothermosol
• Perfadex
• Lifor
• HBS (Hyperosmotic Blood Substitute) Solution
• siRNA (Small Interfering RNA) Transplant Solutions
• Other Solution Types
• 6.2. Global Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kidneys
• Liver
• Lung
• Heart
• Other Organ Types
• 6.3. Global Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Static Cold Storage (SCS) Technique
• Hypothermic Machine Perfusion
• Other Techniques
• 6.4. Global Organ Preservation Solution Market, Sub-Segmentation Of Viaspan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard Viaspan
• Modified Viaspan Formulations
• 6.5. Global Organ Preservation Solution Market, Sub-Segmentation Of Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Custodiol Formulations
• Variants With Additives
• 6.6. Global Organ Preservation Solution Market, Sub-Segmentation Of Renograf, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Renograf Solutions For Kidney Preservation
• Specialty Renograf Formulations
• 6.7. Global Organ Preservation Solution Market, Sub-Segmentation Of Hypothermosol, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypothermosol For Various Organs
• Custom Hypothermosol Mixes
• 6.8. Global Organ Preservation Solution Market, Sub-Segmentation Of Perfadex, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Perfadex For Lung Preservation
• Adapted Perfadex Formulations
• 6.9. Global Organ Preservation Solution Market, Sub-Segmentation Of Lifor, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lifor For Multi-Organ Preservation
• Specific Lifor Adaptations
• 6.10. Global Organ Preservation Solution Market, Sub-Segmentation Of HBS (Hyperosmotic Blood Substitute) Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• HBS For Organ Transport
• Specialty HBS Formulations
• 6.11. Global Organ Preservation Solution Market, Sub-Segmentation Of siRNA (Small Interfering RNA) Transplant Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• siRNA-Based Preservation Methods
• Innovations In siRNA Applications
• 6.12. Global Organ Preservation Solution Market, Sub-Segmentation Of Other Solution Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Experimental Preservation Solutions
• Emerging Organ Preservation Technologies

7. Organ Preservation Solution Market Regional And Country Analysis

• 7.1. Global Organ Preservation Solution Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Organ Preservation Solution Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Organ Preservation Solution Market

• 8.1. Asia-Pacific Organ Preservation Solution Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Organ Preservation Solution Market

• 9.1. China Organ Preservation Solution Market Overview
• 9.2. China Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Organ Preservation Solution Market

• 10.1. India Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Organ Preservation Solution Market

• 11.1. Japan Organ Preservation Solution Market Overview
• 11.2. Japan Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Organ Preservation Solution Market

• 12.1. Australia Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Organ Preservation Solution Market

• 13.1. Indonesia Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Organ Preservation Solution Market

• 14.1. South Korea Organ Preservation Solution Market Overview
• 14.2. South Korea Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Organ Preservation Solution Market

• 15.1. Western Europe Organ Preservation Solution Market Overview
• 15.2. Western Europe Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Organ Preservation Solution Market

• 16.1. UK Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Organ Preservation Solution Market

• 17.1. Germany Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Organ Preservation Solution Market

• 18.1. France Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Organ Preservation Solution Market

• 19.1. Italy Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Organ Preservation Solution Market

• 20.1. Spain Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Organ Preservation Solution Market

• 21.1. Eastern Europe Organ Preservation Solution Market Overview
• 21.2. Eastern Europe Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Organ Preservation Solution Market

• 22.1. Russia Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Organ Preservation Solution Market

• 23.1. North America Organ Preservation Solution Market Overview
• 23.2. North America Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Organ Preservation Solution Market

• 24.1. USA Organ Preservation Solution Market Overview
• 24.2. USA Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Organ Preservation Solution Market

• 25.1. Canada Organ Preservation Solution Market Overview
• 25.2. Canada Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Organ Preservation Solution Market

• 26.1. South America Organ Preservation Solution Market Overview
• 26.2. South America Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Organ Preservation Solution Market

• 27.1. Brazil Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Organ Preservation Solution Market

• 28.1. Middle East Organ Preservation Solution Market Overview
• 28.2. Middle East Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Organ Preservation Solution Market

• 29.1. Africa Organ Preservation Solution Market Overview
• 29.2. Africa Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Organ Preservation Solution Market Competitive Landscape And Company Profiles

• 30.1. Organ Preservation Solution Market Competitive Landscape
• 30.2. Organ Preservation Solution Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Accord Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. BioLife Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lifeline Scientific Overview, Products and Services, Strategy and Financial Analysis

31. Organ Preservation Solution Market Other Major And Innovative Companies

• 31.1. TransMedics Group Inc.
• 31.2. XVIVO Perfusion AB
• 31.3. Organ Recovery Systems Inc.
• 31.4. Bridge to Life Ltd.
• 31.5. Paragonix Technologies Inc.
• 31.6. OrganOx Limited
• 31.7. Shanghai Genext Pharmaceutical Technology
• 31.8. 21st Century Medicine
• 31.9. Institut Georges Lopez
• 31.10. Carnamedica
• 31.11. Global Transplant Solutions
• 31.12. Preservation Solutions Inc.
• 31.13. Essential Pharmaceuticals LLC
• 31.14. Dr. Franz Kohler Chemie GmbH
• 31.15. Advanced Organ Preservation Solutions (OPSL Group)

32. Global Organ Preservation Solution Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Organ Preservation Solution Market

34. Recent Developments In The Organ Preservation Solution Market

35. Organ Preservation Solution Market High Potential Countries, Segments and Strategies

• 35.1 Organ Preservation Solution Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Organ Preservation Solution Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Organ Preservation Solution Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer